Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
LyfeSci Launches to Advance Outcomes-Focused Clinical Research
LyfeSci Research & Innovation, a newly established Contract Research Organization (CRO) led by physicians, is officially launching with a clear mission to transform the clinical research landscape. Rooted in a site-first approach and an unwavering focus on patient outcomes, LyfeSci combines robust clinical insight with a human-centered strategy. The organization offers a broad range of research services that extend from pre-clinical development to studies involving real-world data and evidence.
Hyro Raises $45 Million to Boost AI Agent Use in Healthcare
Hyro, a leader in responsible AI agent technology for the healthcare industry, has announced a $45 million growth funding round led by Healthier Capital, with participation from Norwest, Define Ventures, and existing investors. The funding also includes new strategic backing from Bon Secours Mercy Health, one of Hyro’s long-standing partners, and ServiceNow Ventures, the investment division of ServiceNow. This round comes less than a year after the company’s previous raise and effectively doubles its valuation, bringing total funding to $95 million. The capital infusion will help accelerate the development of AI-driven administrative, operational, and clinical agents that simplify patient access and improve digital experiences across communication channels.
ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology
ConcertAI, a leading provider of oncology-focused AI SaaS and multi-modal data solutions for the healthcare and life sciences sectors, has appointed Dr. Shaalan Beg as its Chief Medical Officer for Oncology. In this new role, Dr. Beg will focus on deepening the company’s clinical engagement by expanding and strengthening the CancerLinQ community. He will act as a bridge between practicing oncologists and ConcertAI’s product development teams, ensuring that evolving clinical needs are translated into innovative and relevant solutions across the company’s offerings.
Altera Digital Health Enables Data Exchange Under TEFCA with Sunrise Axon
Altera Digital Health, a leading global provider of health IT solutions, has announced the launch of its latest innovation, Sunrise Axon. This new solution is designed to deliver clean, real-time patient data directly into clinical workflows within the Sunrise electronic health record (EHR) system, now available to healthcare providers across the United States. By providing normalized and deduplicated data at the point of care, Sunrise Axon aims to improve patient outcomes while boosting provider efficiency and satisfaction.
Hyperfine Enrolls First Patients in PRISM PMR Study
Hyperfine, Inc. , the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced plans for clinical use expansion into the operating room environment, advancing its mission to make brain MRI more accessible across a diversity of care settings. The company plans to establish a foothold in the neurosurgical operating setting by launching a new study to build a body of clinical evidence for Swoop® system use in neurosurgical procedures.
To share your insights, please write to us at sudipto@intentamplify.com
